Allergy Prevention – Where are we now?

The evidence base supporting the use of pHF in primary allergy prevention continues to evolve. When reviewing available literature, it is important to note that the ability to draw conclusions largely depends on the study design. Heat techniques used in the manufacture of infant formula, such as sterilization, can alter the conformation of heat-labile proteins, resulting in the loss of conformational epitopes that elicit allergic response. The protein source, the degree of hydrolysis and the processing techniques used in the manufacture of hydrolysed formula differ across companies and accounts for the differences between formula’s ability to confer allergy preventive effects.

“The protein source, the degree of hydrolysis and the processing techniques used in the manufacture of hydrolysed formula differ across companies and accounts for the differences between formula’s ability to confer allergy preventive effects.”

Click here to read highlights from this video

Click here to watch Prof Szajewska’s speech on Allergy Prevention